New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 27, 2022 - The FDA approved Marius Pharmaceuticals’ Kyzatrex (testosterone undecanoate).
Download PDF
Return to publications
